Collagen
Complex group in Homo sapiens that 2 drugs act on.
- Drugs that act on it: 2
- Approved: 2
- In phases 1 to 3: 0
- Sponsors: 2
- Genes: 25
Who is on it, and how far along
Every drug ChEMBL records acting on COL11A1, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Protein or peptide 2
| Collagenase clostridium histolyticum | Approved | Endo International | Protein or peptide | Hydrolytic enzymeCollagen hydrolytic enzyme | 11 |
| Ocriplasmin | Approved | ThromboGenics | Protein or peptide | Hydrolytic enzymeCollagen hydrolytic enzyme | 0 |
| Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Diminished Ovarian Reserve | Collagenase clostridium histolyticum | Not applicable | Not yet recruiting | Peking University Third Hospital | Oct 28, 2026 |
| Collagenase Injection for Spasticity Management | Collagenase clostridium histolyticum | Early phase 1 | Not yet recruiting | The University of Texas Health Science Center, Houston | Jul 9, 2026 |
| Collagenase Injection for Contracture Management | Collagenase clostridium histolyticum | Early phase 1 | Not yet recruiting | The University of Texas Health Science Center, Houston | Jul 9, 2026 |
| Delayed Dose Collagenase Clostridium Histolyticum (CCH) Protocol for Men With Peyronie's Disease | Collagenase clostridium histolyticum | Phase 4 | Active, not recruiting | Charitable Union for the Research and Education of Peyronie's Disease | Oct 18, 2024 |
| Application of Autologous Adipose Stromal Vascular Fraction in the Treatment of Premature Ovarian Insufficiency | Collagenase clostridium histolyticum | Not applicable | Recruiting | Rui Yang | Jul 1, 2024 |
| Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release | Collagenase clostridium histolyticum | Not applicable | Recruiting | Dartmouth-Hitchcock Medical Center | Mar 26, 2024 |
| Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for Peyronie's Disease | Collagenase clostridium histolyticum | Not applicable | Recruiting | Mayo Clinic | Oct 4, 2023 |
| Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP for Peyronie's Disease | Collagenase clostridium histolyticum | Phase 4 | Active, not recruiting | University of Miami | Mar 20, 2023 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2364188, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets